Epstein-Barr viral (EBV) DNA has been regularly demonstrated in biopsy material from two different human tumors: Burkitt's lymphoma and nasopharyngeal carcinoma (zur Hausen et al. 1970 (zur Hausen et al. , 1974b Nonoyama and Pagano 1973; Wolf et al. 1973) . Patients carrying either of these tumors reveal elevated antibody titers against EB viral capsid antigens (VCA) and in a high percentage also against EBV early antigens (EA) (Henle et al. 1970a,b) .
In Burkitt's lymphoma cells, EBV-specific membrane antigens (Gunven et al. 1970 ) as well as EB-associated nuclear antigens (EBNA) have been demonstrated (Reedman and Klein 1973; Reedman et al. 1974) . The transforming potential of EBV for lymphatic cells has been shown in vitro (Henle et al. 1967; Pope et al. 1968) . Recently the susceptibility of immunoglobulin-synthesizing lymphocytes has been convincingly demonstrated (Klein et al., unpubl.; Schneider and zur Hausen 1975) . It appears that type T lymphocytes lack receptors for EBV absorption (Jondal and Klein 1973) .
A variety of non-Burkitt type B lymphomas do not contain EBV-specific nucleic acids and antigens (Lindahl et al. 1974) , despite the presence of EBV antibodies and the apparent persistence of the virus in cells of the peripheral blood. This provides further indirect evidence for the unique role of EBV in Burkitt's lymphoma.
Nasopharyngeal carcinomas contain, in contrast to Burkitt's lymphoma, a mixed cell population. Islands of nonlymphatic epithelial tumor cells are infiltrated to a varying extent by lymphocytes (Shanmugaratnam 1972) . The degree of lymphatic infiltration has even been used to subclassify this tumor, which was originally named "lymphoepithelioma." The rather well known "lymphotropism" of EBV suggested to some investigators that the viral DNA demonstrated in these tumors by nucleic acid hybridizations should be located within the infiltrating lymphocytes (McAllister 1973) . Thus the nonlymphoid tumor cells would not contain virus-specific products.
Previous data from our laboratory were at variance with this interpretation (Wolf et al. 1973) . They revealed the presence of viral DNA within epithelial cells of the two tumors examined by in situ hybridizations and anticomplementary immunofluorescence. The following is an extension of these studies which establishes further the presence of EB viral DNA within the tumor cells of nasopharyngeal carcinomas.
In addition, the recent induction of lymphoproliferative disease by EBV in marmosets (Shope et al. 1973 ) and an owl monkey (Epstein et al. 1973 ) stimulated us to similar experiments. It was our intention to infect primates with virus isolates from different virus-producing lymphoblastoid lines and to demonstrate virus-specific nucleic acids within the tumor material of such animals. The following report summarizes the results. After varying periods of incubation, the samples were chromatographed on hydroxylapatite columns at 60°C by adding consecutively 4 X 0.5 ml and 1 X 1 ml of 0.14 M phosphate buffer containing 0.4% sodium dodecyl sulfate (SDS). Double-stranded DNA was eluted with 3 x 0.5 ml 0.4 M phosphate buffer.
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RESULTS AND DISCUSSION
EBV DNA in Nasopharyngeal Carcinomas
DNA from biopsies of 34 nasopharyngeal carcinomas was hybridized with EBV cRNA. Eleven of these tumors annealed to a higher extent than DNA derived from Raji cells, a non-virus-producing lymphoblastoid line which was shown in previous experiments to harbor approximately 50 genome equivalents of EBV DNA (Nonoyama and Pagano 1971; zur Hausen et al. 1972) . Only three tumor materials were entirely negative in this test. A careful histological reexamination of remaining material from these biopsies did not reveal any tumorous tissue in two of these, whereas the third one represented an adenocarcinoma.
The careful histological analysis of the tumors showed that all highly hybridizing tumors were of predominantly epithelial morphology, whereas lymphatic cells represented a majority in most of the remaining biopsies. This was in agreement with our previous findings (Wolf et al. 1973) suggesting the presence of EBV DNA within epithelial tumor cells, and was further substantiated by in situ hybridizations of cytological preparations.
For this purpose, tumors were selected which contained almost equal amounts of epithelial and lymphatic cells. A nonhybridizing tumor served as control. Freeze sections of these materials were treated with RNase, alkali-denatured, incubated with EBV cRNA, again treated with RNase and then exposed to autoradiography (Wolf et al. unpubl.) . The result is shown in Figure 1 . Regions of large, pale nuclei are obviously preferentially labeled. Such regions correspond to nonlymphoid cells in the nondenatured sections. No labeling was observed within the control material. These results further confirm and clarify the specific association of EBV with epithelial nasopharyngeal carcinoma cells. The labeling of nonlymphoid cells appears to be confined to the nuclear region, although the denaturation procedure affects the morphology of the cells. These data do not, of course, preclude that some of the lymphoid cells in the nasopharyngeal tumors also carry viral DNA, particularly since EBV-synthesizing lymphoblastoid cell lines have been established from some of these tumors. Additional experiments reveal, however, that the EBV DNA content of the lymphoid fraction in nasopharyngeal carcinomas must be very small and therefore escapes detection in many instances: Recently Claude Desgranges (International Agency for Research on Cancer, Lyon) fractionated cells from nasopharyngeal carcinomas in Ficoll gradients and separated lymphocytes from the remaining tumor cells. From three such tumors, sufficient DNA was obtained to test separately the DNA of the lymphocytic and epithelial fractions. Hybridization of these samples with EBV cRNA was carried out in our laboratory. The data revealed a convincing picture: no significant hybridization was found within the lymphocyte DNA, whereas all three epithelial preparations annealed clearly above the range of Raji cell DNA.
Furthermore, hybridization of DNA from leukocytes of the peripheral blood of patients with nasopharyngeal carcinomas with EBV cRNA did not result in significant annealing. Thus it appears to be firmly established that nasopharyngeal carcinoma represents the second human malignancy, in addition to Burkitt's lymphoma, in which viral DNA can be regularly demonstrated within the tumor cells. Besides the infection of type B lymphocytes (Jondal and Klein 1973), EBV obviously infects specific additional cells of apparently epithelial morphology.
EBV Induction of a Malignant Lymphoma in a
Cottontop Marmoset Shope et al. (1973) and Epstein et al. (1973) induced tumors in marmosets or an owl monkey by injecting them with EBV derived from a marmoset line transformed in vitro by EBV (Miller et al. 1972) or with virus obtained from a Burkitt's lymphoma line. It was our intention to test whether or not EBV directly derived from Kaplan cells, a lymphoblastoid line from a patient with infectious mononucleosis (Diehl et al. 1968) , was also able to Approximately 0.5 genome equivalent was found in the spleen DNA, whereas the DNA mixture from the thymus and unaffected lymph nodes did not enhance the reassociation reaction.
In view of the relative scarcity of tumor cells within the tumor material, the actual concentration of viral DNA should be 4-5 times higher than calculated from the reassociation assay. In situ hybridizations performed on freeze sections of the tumor material failed to reveal significant clustering of grains. This is not surprising since this method represents a rather insensitive assay. It should exclude, however, viral particle synthesis in a few permissive cells as a reason for the observed amount of EBV-specific DNA.
Lymphoblastoid cell lines were obtained from the tumor as well as from spleen material. Approximately 3% of these cells synthesize spontaneously EB viral capsid antigens as observed by immunofluorescence. Typical herpesvirus particles were also found by electron microscopy, and the hybridization rate with EBV cRNA was in the range of the virus-producing P3HR-1 line. Recently, transformation of human umbilical cord lymphocytes was achieved with cell-free virus obtained from these lines.
None of the nine additional cottontop marmosets inoculated either with non-neutralized or neutralized Kaplan or P3HR-1 virus have developed tumors up to now. Except for the tumor-bearing marmoset, no rise in antibodies against EBV antigens was observed in any of the other animals. Even the tumor-carrying marmoset revealed a rather low titer against EB viral capsid antigens. Our failure to detect significant levels of EBV antibodies could be due to the use of FITC-coupled, anti-human y-globulin, since we had no access to anti-cottontop marmoset y-globulin.
CONCLUSION
Our results show that EBV DNA can be regularly demonstrated in nonlymphoid epithelial nasopharyngeal carcinoma cells. Therefore nasopharyngeal carcinoma represents the second human malignancy, in addition to Burkitt's lymphoma, which contains the DNA of a transforming and oncogenic virus within the tumor cells.
It was also shown that EBV derived from a patient with infectious mononucleosis induced a lymphosarcoma in a cottontop marmoset, that viral DNA was found in the tumor material, and that virusspecific antigens as well as typical herpesvirus particles were present in lymphoblastoid cells obtained from the tumor material and kept in tissue culture.
